CN Stock MarketDetailed Quotes

301520 Anhui Wanbang Pharmaceutical Technology

Watchlist
  • 35.90
  • +0.06+0.17%
Market Closed Aug 28 15:00 CST
2.39BMarket Cap21.89P/E (TTM)

Anhui Wanbang Pharmaceutical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
13.47%187.21M
25.14%90.17M
31.07%341.81M
33.43%240.65M
53.28%164.99M
73.61%72.06M
23.54%260.78M
180.36M
7.38%107.64M
41.51M
Operating revenue
13.47%187.21M
25.14%90.17M
31.07%341.81M
33.43%240.65M
53.28%164.99M
73.61%72.06M
23.54%260.78M
--180.36M
7.38%107.64M
--41.51M
Other operating revenue
-61.52%5.29M
----
69.20%24.65M
----
141.61%13.75M
----
36.76%14.57M
----
8.45%5.69M
----
Total operating cost
35.63%141.9M
47.65%65.35M
42.30%230.81M
40.09%159.53M
46.97%104.63M
44.26M
28.79%162.2M
113.87M
23.86%71.19M
Operating cost
26.61%100.89M
40.59%47.83M
34.89%174.53M
32.12%117.13M
46.29%79.69M
--34.02M
29.63%129.39M
--88.65M
20.45%54.47M
----
Operating tax surcharges
87.11%755.01K
132.41%369.06K
52.93%1.16M
27.36%769.57K
23.29%403.5K
--158.8K
-7.72%759.01K
--604.26K
-15.44%327.27K
----
Operating expense
-28.88%2.21M
-28.89%939.77K
2.12%4.54M
8.23%3.79M
37.10%3.11M
--1.32M
11.55%4.44M
--3.5M
29.39%2.27M
----
Administration expense
46.23%13.03M
75.62%6.81M
65.09%20.67M
48.91%14.29M
40.40%8.91M
--3.88M
10.01%12.52M
--9.6M
13.77%6.35M
----
Financial expense
-1,106.81%-2.14M
-3,088.43%-1.33M
-418.92%-4.61M
34.18%-339.57K
46.81%-177.51K
---41.81K
-114.51%-889.3K
---515.89K
1.02%-333.73K
----
-Interest expense (Financial expense)
----
--0
-97.01%115.79
-96.60%115.79
-95.56%115.79
--115.79
-29.40%3.87K
--3.41K
--2.61K
----
-Interest Income (Financial expense)
-1,059.65%-2.16M
-2,634.98%-1.34M
-411.08%-4.63M
33.68%-350.41K
45.70%-186.28K
---48.95K
-109.43%-906.05K
---528.34K
-0.39%-343.03K
----
Research and development
113.95%27.15M
118.06%10.74M
116.21%34.52M
98.48%23.89M
56.51%12.69M
--4.92M
54.31%15.97M
--12.04M
66.52%8.11M
----
Credit Impairment Loss
37.38%-920.6K
22.10%-104K
-81.57%-2.65M
-90.85%-1.15M
-274.10%-1.47M
---133.5K
-74.86%-1.46M
---600.15K
34.86%-393.01K
----
Asset Impairment Loss
-42.33%-1.38M
-43.08%-448.9K
-72.38%-1.45M
-87.25%-1.57M
-84.77%-966.12K
---313.73K
7.45%-843.55K
---838.91K
16.84%-522.88K
----
Other net revenue
10,300.71%11.78M
936.28%7.3M
6.84%8.01M
-54.28%4.45M
-94.46%113.26K
704.92K
269.34%7.5M
9.73M
187.72%2.05M
0
Fair value change income
--11.98M
--6.88M
--3.79M
--858.25K
----
----
----
--0
----
----
Invest income
-23.43%1.33M
-16.45%679.3K
-23.38%2.43M
-17.32%2.01M
10.72%1.74M
--813.02K
71.31%3.18M
--2.43M
134.91%1.57M
----
Asset deal income
--16.44K
----
----
----
----
----
----
----
----
----
Other revenue
-8.24%746.59K
-11.82%299.03K
-10.99%5.9M
-50.81%4.3M
-41.62%813.6K
--339.13K
244.54%6.63M
--8.74M
9.26%1.39M
----
Operating profit
-5.60%57.1M
12.71%32.13M
12.18%119.01M
12.28%85.57M
57.11%60.48M
28.5M
21.68%106.08M
76.22M
-11.46%38.5M
Add:Non operating Income
683.21%2.51M
703.93%291.7K
-85.05%757.59K
-78.62%468.57K
-85.37%320.63K
--36.28K
-31.14%5.07M
--2.19M
-0.53%2.19M
----
Less:Non operating expense
-50.88%49.12K
-56.58%43.42K
1,934.61%118.85K
1,613.74%100.11K
4,208.97%100K
--100K
-97.28%5.84K
--5.84K
-77.02%2.32K
----
Total profit
-1.88%59.56M
13.84%32.38M
7.65%119.64M
9.62%85.94M
49.20%60.7M
108.56%28.44M
17.83%111.15M
78.4M
-10.92%40.69M
13.64M
Less:Income tax cost
-34.24%4.52M
-22.15%2.69M
-6.93%11.55M
-8.90%8.63M
41.59%6.88M
--3.45M
-0.35%12.41M
--9.48M
-20.14%4.86M
----
Net profit
2.25%55.03M
18.81%29.69M
9.48%108.09M
12.17%77.31M
50.23%53.82M
104.95%24.99M
20.60%98.73M
68.93M
-9.50%35.83M
12.19M
Net profit from continuing operation
2.25%55.03M
18.81%29.69M
9.48%108.09M
12.17%77.31M
50.23%53.82M
--24.99M
20.60%98.73M
--68.93M
-9.50%35.83M
----
Net profit of parent company owners
2.25%55.03M
18.81%29.69M
9.48%108.09M
12.17%77.31M
50.23%53.82M
--24.99M
20.60%98.73M
--68.93M
-9.50%35.83M
----
Earning per share
Basic earning per share
-23.15%0.83
-10.00%0.45
1.52%2
12.17%1.5462
50.00%1.08
--0.5
20.12%1.97
--1.3785
-8.86%0.72
----
Diluted earning per share
-23.15%0.83
-10.00%0.45
1.52%2
12.17%1.5462
--1.08
--0.5
--1.97
--1.3785
----
----
Other composite income
0
0
Other composite income of parent company owners
----
----
----
--0
----
----
----
--0
----
----
Total composite income
2.25%55.03M
18.81%29.69M
9.48%108.09M
12.17%77.31M
50.23%53.82M
24.99M
20.60%98.73M
68.93M
-9.50%35.83M
Total composite income of parent company owners
2.25%55.03M
18.81%29.69M
9.48%108.09M
12.17%77.31M
50.23%53.82M
--24.99M
20.60%98.73M
--68.93M
-9.50%35.83M
----
Total composite income of minority owners
----
----
----
--0
----
----
----
--0
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 13.47%187.21M25.14%90.17M31.07%341.81M33.43%240.65M53.28%164.99M73.61%72.06M23.54%260.78M180.36M7.38%107.64M41.51M
Operating revenue 13.47%187.21M25.14%90.17M31.07%341.81M33.43%240.65M53.28%164.99M73.61%72.06M23.54%260.78M--180.36M7.38%107.64M--41.51M
Other operating revenue -61.52%5.29M----69.20%24.65M----141.61%13.75M----36.76%14.57M----8.45%5.69M----
Total operating cost 35.63%141.9M47.65%65.35M42.30%230.81M40.09%159.53M46.97%104.63M44.26M28.79%162.2M113.87M23.86%71.19M
Operating cost 26.61%100.89M40.59%47.83M34.89%174.53M32.12%117.13M46.29%79.69M--34.02M29.63%129.39M--88.65M20.45%54.47M----
Operating tax surcharges 87.11%755.01K132.41%369.06K52.93%1.16M27.36%769.57K23.29%403.5K--158.8K-7.72%759.01K--604.26K-15.44%327.27K----
Operating expense -28.88%2.21M-28.89%939.77K2.12%4.54M8.23%3.79M37.10%3.11M--1.32M11.55%4.44M--3.5M29.39%2.27M----
Administration expense 46.23%13.03M75.62%6.81M65.09%20.67M48.91%14.29M40.40%8.91M--3.88M10.01%12.52M--9.6M13.77%6.35M----
Financial expense -1,106.81%-2.14M-3,088.43%-1.33M-418.92%-4.61M34.18%-339.57K46.81%-177.51K---41.81K-114.51%-889.3K---515.89K1.02%-333.73K----
-Interest expense (Financial expense) ------0-97.01%115.79-96.60%115.79-95.56%115.79--115.79-29.40%3.87K--3.41K--2.61K----
-Interest Income (Financial expense) -1,059.65%-2.16M-2,634.98%-1.34M-411.08%-4.63M33.68%-350.41K45.70%-186.28K---48.95K-109.43%-906.05K---528.34K-0.39%-343.03K----
Research and development 113.95%27.15M118.06%10.74M116.21%34.52M98.48%23.89M56.51%12.69M--4.92M54.31%15.97M--12.04M66.52%8.11M----
Credit Impairment Loss 37.38%-920.6K22.10%-104K-81.57%-2.65M-90.85%-1.15M-274.10%-1.47M---133.5K-74.86%-1.46M---600.15K34.86%-393.01K----
Asset Impairment Loss -42.33%-1.38M-43.08%-448.9K-72.38%-1.45M-87.25%-1.57M-84.77%-966.12K---313.73K7.45%-843.55K---838.91K16.84%-522.88K----
Other net revenue 10,300.71%11.78M936.28%7.3M6.84%8.01M-54.28%4.45M-94.46%113.26K704.92K269.34%7.5M9.73M187.72%2.05M0
Fair value change income --11.98M--6.88M--3.79M--858.25K--------------0--------
Invest income -23.43%1.33M-16.45%679.3K-23.38%2.43M-17.32%2.01M10.72%1.74M--813.02K71.31%3.18M--2.43M134.91%1.57M----
Asset deal income --16.44K------------------------------------
Other revenue -8.24%746.59K-11.82%299.03K-10.99%5.9M-50.81%4.3M-41.62%813.6K--339.13K244.54%6.63M--8.74M9.26%1.39M----
Operating profit -5.60%57.1M12.71%32.13M12.18%119.01M12.28%85.57M57.11%60.48M28.5M21.68%106.08M76.22M-11.46%38.5M
Add:Non operating Income 683.21%2.51M703.93%291.7K-85.05%757.59K-78.62%468.57K-85.37%320.63K--36.28K-31.14%5.07M--2.19M-0.53%2.19M----
Less:Non operating expense -50.88%49.12K-56.58%43.42K1,934.61%118.85K1,613.74%100.11K4,208.97%100K--100K-97.28%5.84K--5.84K-77.02%2.32K----
Total profit -1.88%59.56M13.84%32.38M7.65%119.64M9.62%85.94M49.20%60.7M108.56%28.44M17.83%111.15M78.4M-10.92%40.69M13.64M
Less:Income tax cost -34.24%4.52M-22.15%2.69M-6.93%11.55M-8.90%8.63M41.59%6.88M--3.45M-0.35%12.41M--9.48M-20.14%4.86M----
Net profit 2.25%55.03M18.81%29.69M9.48%108.09M12.17%77.31M50.23%53.82M104.95%24.99M20.60%98.73M68.93M-9.50%35.83M12.19M
Net profit from continuing operation 2.25%55.03M18.81%29.69M9.48%108.09M12.17%77.31M50.23%53.82M--24.99M20.60%98.73M--68.93M-9.50%35.83M----
Net profit of parent company owners 2.25%55.03M18.81%29.69M9.48%108.09M12.17%77.31M50.23%53.82M--24.99M20.60%98.73M--68.93M-9.50%35.83M----
Earning per share
Basic earning per share -23.15%0.83-10.00%0.451.52%212.17%1.546250.00%1.08--0.520.12%1.97--1.3785-8.86%0.72----
Diluted earning per share -23.15%0.83-10.00%0.451.52%212.17%1.5462--1.08--0.5--1.97--1.3785--------
Other composite income 00
Other composite income of parent company owners --------------0--------------0--------
Total composite income 2.25%55.03M18.81%29.69M9.48%108.09M12.17%77.31M50.23%53.82M24.99M20.60%98.73M68.93M-9.50%35.83M
Total composite income of parent company owners 2.25%55.03M18.81%29.69M9.48%108.09M12.17%77.31M50.23%53.82M--24.99M20.60%98.73M--68.93M-9.50%35.83M----
Total composite income of minority owners --------------0--------------0--------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg